| Literature DB >> 20046887 |
A Douglas Kinghorn1, Esperanza J Carcache de Blanco, Hee-Byung Chai, Jimmy Orjala, Norman R Farnsworth, D Doel Soejarto, Nicholas H Oberlies, Mansukh C Wani, David J Kroll, Cedric J Pearce, Steven M Swanson, Robert A Kramer, William C Rose, Craig R Fairchild, Gregory D Vite, Stuart Emanuel, David Jarjoura, Frederick O Cope.
Abstract
A collaborative multidisciplinary research project is described in which new natural product anticancer drug leads are obtained from a diverse group of organisms, constituted by tropical plants, aquatic cyanobacteria, and filamentous fungi. Information is provided on how these organisms are collected and processed. The types of bioassays are indicated in which crude extracts of these acquisitions are tested. Progress made in the isolation of lead bioactive secondary metabolites from three tropical plants is discussed.Entities:
Year: 2009 PMID: 20046887 PMCID: PMC2765058 DOI: 10.1351/PAC-CON-08-10-16
Source DB: PubMed Journal: Pure Appl Chem ISSN: 0033-4545 Impact factor: 2.453